Business Wire

IBSA

16.7.2024 20:01:35 CEST | Business Wire | Press release

Share
Alberto Bona and the Class40 IBSA Cross the Finish Line of the Transat Québec Saint-Malo in Sixth Position

Alberto Bona and Class40 IBSA, with Luca Rosetti and Pablo Santurde del Arco on board, crossed the finish line of the Transat Québec Saint-Malo at 4:34:42 CEST on July 15, in sixth position, after covering 2,800 miles in 14 days, 20 hours, 19 minutes and 42 seconds. However, they ended up in seventh place in the official ranking due to a compensation granted to Antoine Magré’s E. Leclerc – Ville La Grand for diverting her course to rescue Acrobatica and Alberto Riva’s crew.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716844847/en/

At dawn on the last day of navigation, the Class40 IBSA – the protagonist of a sensational comeback of over 230 miles over the last week – managed to grab the sixth position in a fleet reduced to 19 boats, after Riva’s wreck and the withdrawal of 5 other boats, including Ambrogio Beccaria’s. The last hours were very challenging: a disturbance with a Southerly wind favoured a wonderful upwind finish in front of the Môle des Noires, the outer breakwater that marks the entrance to the port of Saint-Malo.

It was an exciting regatta and I enjoyed it a lot”, stated Bona, “because we experienced all possible conditions and different ways of sailing. We spent two days on the river, which for me was an entirely new experience, then we went through the banks of Newfoundland, in search of the lows up to the far North, so much so that we found ourselves 350 miles from Greenland. I had never sailed so far North, where the sea is a blue I had never seen. It’s been a difficult race, because the weather was never constant. When we found ourselves at the back of the fleet and the models indicated up to 400 miles of delay we were not discouraged. This changed everything: we started to recover, without ever giving up. Closing less than ten miles from the leader, given the preconditions, is a good result”.

The entire IBSA”, announced Antonio Melli, Vice President of IBSA Group, “followed this regatta with great interest, the difficulties experienced by the crews, the withdrawals and the wreck. Seeing that our Class40 – with Alberto Bona, Pablo Santurde del Arco and Luca Rosetti – finished in seventh position is a great satisfaction. We saw the commitment and determination, and we are honoured to have been protagonists of this regatta, which inspired all of us deeply: a great sporting and human undertaking”.

THE FIRST TIME ON THE RIVER – The Transat Québec Saint-Malo started at 2:00 pm Canadian time on June 30 from Quebec City. The impact with the St. Lawrence River, its currents and the “four seasons in one hour” weather was immediately evident: indeed, a few minutes from the start a gust of wind hit the fleet, a harbinger of the many difficulties that characterised this regatta. The difficult part of the river, represented by the first 140 miles, was covered in about 20 hours by the Class40 IBSA, which found herself in fourth position: “It was a really intense regatta”, reported Luca Rosetti. “The exit from the river was particularly complicated, with much less wind than expected. Throughout the trial the weather was unstable and made it very difficult to make decisions. Especially on the river, we fought like in a race between buoys; these were agitated phases in a hyper-competitive fleet, everyone always looking for maximum speed”.

THE BANKS OF TERRANOVA – After 2 days and 6 hours of navigation, the Class40 IBSA entered the Gulf of St. Lawrence in sixth position, just 3 miles from the head of the group. The first 500 miles of the race were sailed in this configuration, with about half of the fleet fighting for the top positions. The next part of the race saw the passage south of the island of Newfoundland, the gateway to the Atlantic, and it was not a simple one: around 300 miles with little wind, where the first accident of the regatta occurred, forcing Italian sailor Claudia Conti to abandon La Boulangère Bio due to an injury. IBSA left Newfoundland in fifth place, 5 miles behind the leader, having covered around 800 miles in five days, with a lighter wind than expected.

THE DANGERS OF THE ATLANTIC – On the sixth day, after leaving the Newfoundland banks, there was the first turning point of the regatta: the Class40 IBSA, together with the leading group of four boats, chose a firm Northern route, with the aim of going around a low and thus finding themselves in the best conditions to run fast. However, the chosen strategy turned out to be less promising than expected: on the morning of July 8, the entire group found itself in the back. Alberto therefore decided to return to the great circle, accumulating a 180-mile gap which in the darkest moment, the afternoon of July 8, would even become 242. “It was difficult to choose the right route”, explained Bona; “we were seduced by the North option, and then managing it became very complicated, especially when the simulations had us 400 miles behind the leader. We rolled up our sleeves, and we were so far North that we were caught in a newly formed disturbance, which allowed us to descend very quickly and recover”.

THE STORM – But it’s when the going gets tough that the tough really start to play, and Alberto’s team showed great ability to react. Two long days going upwind, with very strong winds, put everything and everyone to the test. The Class40 IBSA found herself in the right position and did not suffer the storm; on the contrary, she rode it out. She then began to regain mile after mile, with a high relative speed compared to the leaders, recovering up to the seventh position and a full 170-mile gap. “Going this far North was a big risk”, commented Pablo Santurde del Arco, “but we’ve been very good at putting everything back into play, managing to react and handle a long and tiring upwind beat, always leaning and bumping the waves”.

THE ACCIDENTS – Between 9 and 10 July, in an increasingly complicated regatta, there were two accidents involving Italian skippers Alberto Riva and Ambrogio Beccaria. Alberto Riva was the protagonist of a shipwreck caused by a collision with an oil tanker, while a few hours later Ambrogio Beccaria detected structural damage to the hull, which was taking on water, thus forcing him to retire. Both crews repaired to the Azores islands, welcomed by the local community. “We had very little information in relation to what happened to Alberto Riva; we were very worried. When these things happen you realise what the risk is. Knowing they were okay was a huge relief”, said Bona.

AIR OF HOME – July 11 saw more clement weather; finally liveable conditions on the boat; the possibility of checking the hull after the long and wild upwind run; a well-established seventh position; and 2,000 miles covered. On the night between 14 and 15 July, the Class40 IBSA passed the island of Ouessant and entered the English Channel, gaining another position: sixth place, ten miles from the leader, a feat then nullified in the ranking due to the compensation granted to E. Leclerc for diverting her course to rescue Acrobatica; thus, the Class40 IBSA was back in seventh place in the official ranking, released on July 16.

At sea, at 2:00 pm on July 15 the Southerly wind set up an extraordinary upwind finish in front of the mouth of the port of Saint-Malo, with many people lined up along the breakwater to celebrate the arrivals. At the finish line, Alberto Bona, Pablo Santurde del Arco and Luca Rosetti entered – with a solid three-way embrace – the history of this difficult regatta.

THE PROJECT: The three-year project Sailing into the Future. Together was launched in January 2022. The partnership between IBSA and skipper Alberto Bona was born on common bases and values, ​​and aims to use sailing as a corporate communication vehicle towards the market and the nautical world. Ingenuity, courage, innovation, responsibility are elements that unite IBSA and Alberto, and the oceanic challenge, in addition to the sporting competition, also metaphorically represents the company’s history, philosophy and vision, which are always oriented towards and are part of a path that brings IBSA increasingly closer to the topic of environmental and social sustainability, with a particular focus on inclusive sailing projects for people with disabilities. In November 2022, the Route du Rhum was the first sporting stage of the project Sailing into the Future. Together. In 2023, Bona and the Class40 IBSA participated in six regattas, including the Rolex Fastnet Race and the Transat Jacques Vabre. With two victories and three podiums, the record for the highest number of miles covered in 24 hours and over 15,000 miles sailed, Bona won first place overall in the Class40 International Championship. In 2024, between April and July, he will face two of the toughest transatlantic races on the international scene: the Transat CIC from Lorient (France) to New York and the Quebec Saint-Malo (from Canada to France).

THE SKIPPER: Alberto Bona is from Turin, and has a degree in philosophy. As a university student, he won the Panerai trophy aboard Stormvogel, fast ULDB and historic boat with which he crossed the Atlantic Ocean for the first time, winning the ARC with a New Zealand crew. In 2012 he took part in the Minitransat, finishing 5th, one of the best Italian results ever in this category. In 2015, he switched to the prototype category Mini 6.50 with Promostudi La Spezia: he won the Italian championship and finished second in the ocean crossing Les Sables-Azores. In 2017 he discovered the Class40: on Giovanni Soldini’s former Telecom Italia, he participated in the Transat Jacques Vabre, where he was forced to withdraw when he was in sixth place. In 2019 he was aboard the Maserati Multi 70 trimaran, one of the world’s fastest boats, where he practiced on the foils before moving on to the Figaro Beneteau 3, aboard which he participated in the Solitaire; the only Italian registered, in 2020 he finished 7th among the rookies in the first year and 16th overall. In 2021 he won the Italian offshore team title and the Europeans in mixed doubles aboard the Figaro 3. In 2022 he started the new project in partnership with IBSA: after an eighth place in the Route du Rhum 2022, in 2023 Alberto won the Class40 International Championship, closing a season with three podiums and over 15,000 miles covered.

THE BOAT: Designed by French naval architect Sam Manuard and built by the JPS Production shipyard, Alberto Bona’s boat is a Class40 Mach 5 model. Its main characteristics are: scow bow – rounded and with a wider and flatter shape than standard bows – designed to stay high above the water and avoid being submerged; all-round hull, particularly performing in conditions of strong tailwinds; and a large, shielded cockpit, to face extreme conditions of navigation in as comfortable and safe as possible positions.

IBSA: IBSA (Institut Biochimique SA) is a Swiss multinational pharmaceutical Company, founded in 1945 in Lugano. Today, its products are present in over 90 countries on 5 continents, through the Company’s 20 subsidiaries located in Europe, China, and the United States. The company has a consolidated turnover of 986 million CHF, and employs over 2,300 people between headquarters, subsidiaries and production sites. IBSA holds 90 families of approved patents, plus others under development, as well as a vast portfolio of products, covering 10 therapeutic areas: reproductive medicine, endocrinology, pain and inflammation, osteoarticular, aesthetic medicine, dermatology, uro-gynaecology, cardiometabolic, respiratory, consumer health. It is also one of the largest operators worldwide in the area of reproductive medicine, and one of the world’s leaders in hyaluronic acid-based products. IBSA has based its philosophy on four pillars: Person, Innovation, Quality and Responsibility.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240716844847/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release

A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye